Pharvaris
PHVS
21 hedge funds and large institutions have $174M invested in Pharvaris in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
5% more funds holding
Funds holding: 20 → 21 (+1)
0.12% less ownership
Funds ownership: 67.43% → 67.32% (-0.12%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
65% less capital invested
Capital invested by funds: $494M → $174M (-$320M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$1.42M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$962K |
| 3 |
Millennium Management
New York
|
+$449K |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$78.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$75.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$1.34M |
| 2 |
SCM
Suvretta Capital Management
New York
|
-$1.26M |
| 3 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$981K |
| 4 |
VP
venBio Partners
San Francisco,
California
|
-$74.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$18K |
PHVS Hedge Fund Activity: Q3 2022 in Review
21 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q3 2022, worth a combined $174M — down 65% from $494M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PHVS positions and 1 closed out — a net gain of 1 holder — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Novo Holdings A/S, adding an estimated $1.42M. The largest seller was Deerfield Management, cutting an estimated $1.34M.
- 21 institutional investors held Pharvaris (PHVS) as of Q3 2022, up from 20 in Q2 2022.
- Funds reported $174M of Pharvaris stock for Q3 2022, down 65% quarter-over-quarter.
- 2 funds opened new Pharvaris positions in Q3 2022 and 1 closed out, a net change of +1 holder.
- The largest Pharvaris buyer in Q3 2022 was Novo Holdings A/S, an estimated $1.42M added.
- The largest Pharvaris seller in Q3 2022 was Deerfield Management, an estimated $1.34M sold.
Based on aggregated 13F filings for Q3 2022.